Skip to main content
. 2009 Aug 19;114(15):3255–3264. doi: 10.1182/blood-2009-06-229898

Table 2.

Patients' prognostic factors of miRNA screening cohort

n/%
Binet stage
    A 33/50 (66.0 %)
    B 11/50 (22.0%)
    C 6/50 (12.0%)
Cytogenetics
    Normal 12/45 (26.6%)
    del13q14 25/45 (55.5%)
    Homozygous del13q14 6/45 (13.2%)
    Trisomy 12 3/45 (6.6%)
    del11q 3/45 (6.6%)
    del17p 1/45 (2.2%)

Clinical and molecular features including cytogenetic analysis by FISH of 50 patients being diagnosed with CLL were assessed before miRNA profiling was performed.